Clinical Trial Detail

NCT ID NCT01706458
Title Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

prostate adenocarcinoma

Therapies

pTVG-HP plasmid DNA vaccine

Sipuleucel-T

Age Groups: adult

No variant requirements are available.